Showing CypComp Card for CC00417: CMV423 (CypReact Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:20:37 UTC
Last Updated2019-10-01 21:37:56 UTC
CypComp IDCC00417
Compound Information
NameCMV423
Structure ImageKngxenhwynlkbu uhfffaoysa n
InChIKeyKNGXENHWYNLKBU-UHFFFAOYSA-N
PubChem ID489128
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
ReactantNon-ReactantNon-ReactantReactantReactantNon-ReactantNon-ReactantNon-ReactantReactant
References
  1. Bournique B, Lambert N, Boukaiba R, Martinet M: In vitro metabolism and drug interaction potential of a new highly potent anti-cytomegalovirus molecule, CMV423 (2-chloro 3-pyridine 3-yl 5,6,7,8-tetrahydroindolizine I-carboxamide). Br J Clin Pharmacol. 2001 Jul;52(1):53-63. doi: 10.1046/j.0306-5251.2001.01413.x. [PubMed:11453890 ]
Download FileCC00417.sdf